These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17962855)

  • 1. Relationship between serum concetrations of type III procollagen, hyluronic acid and histopathological findings in the liver of HCV-positive blood donors.
    Camacho VR; Silveira TR; Oliveira JR; Barros SG; Cerski CT
    Arq Gastroenterol; 2007; 44(2):118-22. PubMed ID: 17962855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
    Lichtinghagen R; Pietsch D; Bantel H; Manns MP; Brand K; Bahr MJ
    J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum fibrosis markers in diagnosing liver fibrosis].
    Liu J; Wang JY; Lu Y
    Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):475-7. PubMed ID: 16831325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Procollagen III and laminin in chronic viral hepatopathies].
    Montalto G; Soresi M; Aragona F; Tripi S; Carroccio A; Anastasi G; Magliarisi C; Barresi E; Notarbartolo A
    Presse Med; 1996 Jan; 25(2):59-62. PubMed ID: 8745719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolylhydroxylase and procollagen type III in long-term survivors of acute lymphoblastic leukemia (ALL): a biochemical approach to HCV-related liver disease.
    Leonardi S; La Spina M; La Rosa M; Schilirò G
    Med Pediatr Oncol; 2003 Jul; 41(1):17-20. PubMed ID: 12764737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C.
    Patel K; Lajoie A; Heaton S; Pianko S; Behling CA; Bylund D; Pockros PJ; Blatt LM; Conrad A; McHutchison JG
    J Gastroenterol Hepatol; 2003 Mar; 18(3):253-7. PubMed ID: 12603524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum hyaluronic acid reflects the effect of interferon treatment on hepatic fibrosis in patients with chronic hepatitis C.
    Yamada M; Fukuda Y; Koyama Y; Nakano I; Urano F; Katano Y; Hayakawa T
    J Gastroenterol Hepatol; 1996 Jul; 11(7):646-51. PubMed ID: 8840240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence factors of serum fibrosis markers in liver fibrosis.
    Tao J; Peng HQ; Cai WM; Dong FQ; Weng HL; Liu RH
    World J Gastroenterol; 2003 Nov; 9(11):2497-500. PubMed ID: 14606083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
    Xie SB; Yao JL; Zheng SS; Yao CL; Zheng RQ
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection.
    Wong VS; Hughes V; Trull A; Wight DG; Petrik J; Alexander GJ
    J Viral Hepat; 1998 May; 5(3):187-92. PubMed ID: 9658372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell immune response is correlated with fibrosis and inflammatory activity in hepatitis B cirrhotics.
    Tang JT; Fang JY; Gu WQ; Li EL
    World J Gastroenterol; 2006 May; 12(19):3015-9. PubMed ID: 16718780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between staging of hepatic fibrosis and the levels of serum biochemistry.
    Xu GG; Luo CY; Wu SM; Wang CL
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):246-8. PubMed ID: 14612277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver.
    Tsukamoto T; Yamamoto T; Ikebe T; Takemura S; Shuto T; Kubo S; Hirohashi K; Kinoshita H
    Hepatogastroenterology; 2004; 51(57):777-80. PubMed ID: 15143915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Accuracy of Serum Hyaluronan for Detecting HCV Infection and Liver Fibrosis in Asymptomatic Blood Donors.
    Rodart IF; Pares MM; Mendes A; Accardo CM; Martins JRM; Silva CB; Carvalho FO; Barreto JA; Reis MG; Tersariol ILS; Nader HB
    Molecules; 2021 Jun; 26(13):. PubMed ID: 34202190
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis.
    Xie SB; Yao JL; Zheng RQ; Peng XM; Gao ZL
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):69-72. PubMed ID: 14607650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis.
    Guéchot J; Laudat A; Loria A; Serfaty L; Poupon R; Giboudeau J
    Clin Chem; 1996 Apr; 42(4):558-63. PubMed ID: 8605673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group.
    McHutchison JG; Blatt LM; de Medina M; Craig JR; Conrad A; Schiff ER; Tong MJ
    J Gastroenterol Hepatol; 2000 Aug; 15(8):945-51. PubMed ID: 11022838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of liver fibrosis in chronic hepatitis C patients with no response to interferon-alpha therapy: including quantitative assessment by a morphometric method.
    Yagura M; Murai S; Kojima H; Tokita H; Kamitsukasa H; Harada H
    J Gastroenterol; 2000; 35(2):105-11. PubMed ID: 10680665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.